(By Rylee Wilson for Becker’s Hospital Review)
Insurers are reporting rising costs in the Medicare Advantage business but differ in their predictions of how these trends will affect their business in 2024.
On a Feb. 6 call, Centene executives reassured investors the company priced for rising costs in its 2024 guidance. Continue reading here…
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.